Popular Categories
Results for 'Alyssa Kitlas'
New Rapid Syphilis Testing Resources Available on NCSD Website
The National Coalition of STD Directors (NCSD) has added rapid syphilis testing (RST) resources to its website at www.ncsddc.org/rst....
Dec 16, 2015 | Alyssa Kitlas
New Materials on Reimbursement for Female Condoms
The National Coalition of STD Directors and the National Family Planning and Reproductive Health Association released two new...
Dec 15, 2015 | Alyssa Kitlas
CDC Analysis Shows National Trends in HIV Diagnosis from 2005-2014
The CDC released a new national analysis that showed an almost 20% decline in HIV diagnoses in the United States from 2005 to 2014....
Dec 14, 2015 | Alyssa Kitlas
Latest CDC Act Against AIDS Initiative: Doing It
The CDC launched its latest communications campaign, Doing It, a new national bilingual campaign that emphasizes the importance of HIV...
Dec 11, 2015 | Alyssa Kitlas
Issue Brief on Transgender Women and PrEP
The National Center for Innovation in HIV Care released an issue brief entitled Transgender Women and Pre-Exposure Prophylaxis: What...
Dec 04, 2015 | Alyssa Kitlas
Case Study on Leveraging Lessons Learned in an Immunization Program to Increase...
Cardea Services released a case study examining the experience of The Arizona Partnership for Immunization with third-party billing...
Dec 03, 2015 | Alyssa Kitlas
PrEP: A Powerful Prevention Tool
The CDC released its 2015 HIV Vital Signs report highlighting PrEP as an essential component in accelerating progress in HIV...
Dec 01, 2015 | Alyssa Kitlas
Nearly Half of Hepatitis C Patients on Medicaid Denied Coverage for Life-Saving...
New research from the University of Pennsylvania Perelman School of Medicine shows that 50% of Medicaid patients infected with chronic...
Nov 30, 2015 | Alyssa Kitlas
Narcan® (Naloxone Hydrochloride) Nasal Spray Approved By U.S. Food and Drug...
The FDA approved NARCAN® (naloxone hydrochloride) Nasal Spray for the emergency treatment of known or suspected opioid overdose. In...
Nov 27, 2015 | Alyssa Kitlas
New Rapid Syphilis Testing Resources Available on NCSD WebsiteThe National Coalition of STD Directors (NCSD) has added rapid syphilis testing (RST) resources to its website at www.ncsddc.org/rst. This section will act as a clearinghouse for a variety of RST resources. Visit the website for NCSD’s updated RST tri-fold, past webinars on syphilis testing, and individual state RST protocols. Dec 16, 2015 | Alyssa Kitlas |
New Materials on Reimbursement for Female CondomsThe National Coalition of STD Directors and the National Family Planning and Reproductive Health Association released two new resources for Female Condoms. The first piece is a factsheet for providers with background on the female condom and its reimbursability, including codes and a prescription sample. The second piece is a palm card designed for patients to educate […] Dec 15, 2015 | Alyssa Kitlas |
CDC Analysis Shows National Trends in HIV Diagnosis from 2005-2014The CDC released a new national analysis that showed an almost 20% decline in HIV diagnoses in the United States from 2005 to 2014. Unfortunately, the same level of success was not seen among all gay and bisexual men and in Southern states. Read the full press release. Among the findings: From 2005-2014, the annual […] Dec 14, 2015 | Alyssa Kitlas |
Latest CDC Act Against AIDS Initiative: Doing ItThe CDC launched its latest communications campaign, Doing It, a new national bilingual campaign that emphasizes the importance of HIV testing for all people aged 18-64, at the National HIV Prevention Conference. Overall, the campaign emphasizes that HIV testing is a normal part of life—everyone is Doing It. Testing campaign advertisements feature a diverse group of participants, […] Dec 11, 2015 | Alyssa Kitlas |
Issue Brief on Transgender Women and PrEPThe National Center for Innovation in HIV Care released an issue brief entitled Transgender Women and Pre-Exposure Prophylaxis: What We Know and What We Still Need to Know. It is estimated that HIV prevalence among transgender women is 49 times higher than in the general adult population, with 19.1% of transgender women worldwide currently living with HIV. The […] Dec 04, 2015 | Alyssa Kitlas |
Case Study on Leveraging Lessons Learned in an Immunization Program to Increase Sustainability of STD, HIV, and Other Related ServicesCardea Services released a case study examining the experience of The Arizona Partnership for Immunization with third-party billing that includes lessons learned that are relevant to STD and HIV programs looking to increase sustainability. Public health systems, including state and local STD programs and public health laboratories, are adapting to the changing health care environment. While these... Dec 03, 2015 | Alyssa Kitlas |
PrEP: A Powerful Prevention ToolThe CDC released its 2015 HIV Vital Signs report highlighting PrEP as an essential component in accelerating progress in HIV prevention and calls for collaborative action between providers, medical and professional associations, state and local health departments, and community based organizations to get PrEP to those most in need. The report includes two Morbidity and Mortality Weekly Reports... Dec 01, 2015 | Alyssa Kitlas |
Nearly Half of Hepatitis C Patients on Medicaid Denied Coverage for Life-Saving Drugs, Researchers ReportNew research from the University of Pennsylvania Perelman School of Medicine shows that 50% of Medicaid patients infected with chronic hepatitis C were denied coverage of newer, life-saving antiviral drugs prescribed by their doctors. Explanations included that the therapies were not considered “a medical necessity,” the patients had tested positive for alcohol/drugs, and other reasons.... Nov 30, 2015 | Alyssa Kitlas |
Narcan® (Naloxone Hydrochloride) Nasal Spray Approved By U.S. Food and Drug AdministrationThe FDA approved NARCAN® (naloxone hydrochloride) Nasal Spray for the emergency treatment of known or suspected opioid overdose. In 2013, opioid overdose related deaths claimed over 24,500 lives and this number continues to grow. NARCAN Nasal Spray, a ready-to-use, needle-free device, delivers a 4 mg dose of naloxone in a single 0.1 ml nasal spray. NARCAN […] Nov 27, 2015 | Alyssa Kitlas |
Subscribe Today
Sign Up for the E-mail Digests
Create an account or login to MyNACCHO and go to "My Subscriptions."
SUBSCRIBE NOWPARTNER ARTICLES
More NACCHO Blogs
Check out all the NACCHO blogs.